PlainPharmaWatch

CMS Open Payments · Tool

Responsive Arthroscopy Inc vs Johnson & Johnson Surgical Vision, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Responsive Arthroscopy Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 858, versus 163 for the other company. Its single largest recorded recipient represents 0.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Responsive Arthroscopy Inc
HHI 858 · top recipient 0.2%
Ranked #1,086 of 1,838 companies by HHI
Johnson & Johnson Surgical Vision, Inc.
HHI 163 · top recipient 0.1%
Ranked #1,607 of 1,838 companies by HHI

Payment Overview

Total Payments
$4.1M
% of Industry
0.0%
Transactions
160
Avg per Transaction
$25.9K
Recipients
116
Avg per Recipient
$35.7K
Payment Types
4
Top Payment Type
Consulting Fee
Total Payments
$4.2M
% of Industry
0.0%
Transactions
6,243
Avg per Transaction
$668.77
Recipients
6,052
Avg per Recipient
$689.88
Payment Types
7
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Responsive Arthroscopy Inc vs Johnson & Johnson Surgical Vision, Inc. - total reported payments in CMS Open Payments PY2024

Johnson & Johnson Surgical…$4.2MResponsive Arthroscopy Inc$4.1M

Payment Types Breakdown

Responsive Arthroscopy Inc

Consulting Fee $34.1K

0.8%

Royalty or License $30.7K

0.7%

Travel and Lodging $2.8K

0.1%

Food and Beverage $1.8K

0.0%

Johnson & Johnson Surgical Vision, Inc.

Consulting Fee $1.2M

28.3%

Food and Beverage $284.4K

6.8%

Grant $37.5K

0.9%

Compensation for Services Other Than Consulting $22.1K

0.5%

Space Rental or Facility Fees $16.5K

0.4%

Travel and Lodging $16.0K

0.4%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Responsive Arthroscopy Inc

  1. 1

    Thomas Edwards

    $11,254.20 · 5 txns

  2. 2

    JOHN SPERLING

    $8,718.38 · 7 txns

  3. 3

    ALLAN HUNT

    $7,232.60 · 7 txns

  4. 4

    ROBERT LAPRADE

    $6,600.00 · 6 txns

  5. 5

    JOHANNES COETZEE

    $4,820.24 · 10 txns

Johnson & Johnson Surgical Vision, Inc.

  1. 1

    JOSHUA A YOUNG

    $89,829.82 · 5 txns

  2. 2

    DANIEL H CHANG

    $62,312.86 · 63 txns

  3. 3

    GEORGE WARING

    $48,762.66 · 36 txns

  4. 4

    SUMIT GARG

    $48,636.77 · 38 txns

  5. 5

    NIRAJ NAYAN DESAI

    $43,218.21 · 30 txns

Summary Comparison

Metric Responsive Arthroscopy Inc Johnson & Johnson Surgical Vision, Inc.
Total Payments $4.1M $4.2M
% of Industry Total 0.0% 0.0%
Transaction Count 160 6,243
Avg per Transaction $25.9K $668.77
Recipient Count 116 6,052
Avg per Recipient $35.7K $689.88
Payment Type Count 4 7
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.